-880.34
79,454.47
-1.1%
Market Closed
1,377.75
-1.93%
1,889.2
-1.93%
-5.25
3,442.2
-0.15%
1,848.25
-1.21%
1,388.7
-3.16%
10.65
779.4
1.39%
1,507.45
-0.25%
2,333.95
-0.9%
8,640.2
-2.02%
-6.85
423.5
-1.5%
786.8
0.72%
3,445.7
3.77%
1,569.9
-0.63%
1,744.85
-1.23%
2,103.75
-0.11%
12,252.35
-1%
2,982.75
-1.59%
-17.85
1,153.35
-1.44%
11,373.6
-2.15%
-5.15
334.6
-1.52%
1,970.3
-1.77%
147.35
3,510.8
4.38%
4,500.9
1.84%
1.65
234.75
0.49%
1,307.1
-1.73%
299.55
-2.7%
708.5
3.9%
2,251.75
-1.48%
3,973.3
0.02%
0.65
241.9
0.27%
382.65
-0.66%
956.85
0.19%
315.75
2.92%
-17.3
2,323.8
-0.74%
2,300.35
0.02%
226.95
-1.09%
7,683.5
-0.58%
513.5
-1.26%
139.95
-0.46%
5,100.05
-0.52%
-114.1
5,114.15
-2.18%
2,633.6
-2.42%
142.75
-0.63%
408.1
0.16%
1,699.1
-1.76%
496.3
1.52%
407.85
0.2%
6,001.1
1.08%
248.1
-1.25%
-23.75
631.5
-2.79%
-880.34
79454.47
-1.1%
Market Closed

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules
DSIJ Intelligence
/ Categories: Trending, DSIJ News

Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules

On Friday, Alembic Pharmaceuticals informed the exchanges that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Doxepin Hydrochloride Capsules, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg and 100 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product, Sinequan Capsules of Pfizer Inc. This drug has an estimated market size of US$ 41 million for twelve months ending December 2020 according to IMS Health (IQVIA).

The abovementioned drug is recommended to treat depression and/or anxiety associated to alcoholism, organic disease, and for the treatment of psychoneurotic patients. In addition, it is recommended for psychotic depressive disorders with associated anxiety and manic-depressive disorders.

Alembic has a cumulative total of 141 ANDA approvals (124 final approvals and 17 tentative approvals) from USFDA.

At 2 pm on Friday, the shares of Alembic Pharmaceuticals were trading at Rs 996.50, down by 0.72 per cent or Rs 7.20 per share, against a 0.28 per cent decline in the benchmark index. The 52-week high of the company is recorded at Rs 1,150 and the 52-week low is recorded at Rs 641.55 on BSE.

Previous Article Indian markets plunge further; Sensex slips below 48,000 mark, Zomato Founder Deepinder Goyal denies IPO DRHP filing
Next Article Tata Elxsi zooms to lifetime high
Print
857 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR